Details

Published: 30 June 2017

Read more ...

Details

Published: 19 June 2017

The «Medsintez» plant took part in the exhibition of achievements of the domestic pharmaceutical and medical industry held as part of the state program named 'Pharmaceutical and Medical Industry Development for 2013-2020' in Moscow.

Read more ...

Details

Published: 05 July 2016

Insulin developers from Sverdlovsk will receive 183 million roubles to expand their production. Almost 200 million roubles will be invested in the insulin production in the Urals. The money will be allocated by the Industry Development Fund. The loan will be directed to the expansion of the first biopharmaceutical import-substituting production of genetically engineered insulin.

Read more ...

Details

Published: 30 December 2014

Triazavirin has been recommended for use by the Ministry of Health of the Russian Federation.

Read more ...

Details

Published: 29 December 2014

Ural Triazavirin has finally been released. This antiviral drug developed by Sverdlovsk scientists has come pharmacies today. This is such a long-awaited event that the Ural medicine has been sold out briskly.

Read more ...